Jump Financial’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,400
| Closed | -$170K | – | 1754 |
|
|
2024
Q3 | $170K | Buy |
16,400
+1,200
| +8% | +$12.4K | ﹤0.01% | 1487 |
|
|
2024
Q2 | $197K | Buy |
+15,200
| New | +$197K | ﹤0.01% | 1564 |
|
|
2024
Q1 | – | Sell |
-31,868
| Closed | -$300K | – | 1995 |
|
|
2023
Q4 | $300K | Sell |
31,868
-24,768
| -44% | -$233K | 0.01% | 1332 |
|
|
2023
Q3 | $633K | Buy |
56,636
+16,608
| +41% | +$186K | 0.02% | 888 |
|
|
2023
Q2 | $857K | Buy |
40,028
+24,060
| +151% | +$515K | 0.03% | 759 |
|
|
2023
Q1 | $646K | Buy |
15,968
+7,748
| +94% | +$313K | 0.03% | 779 |
|
|
2022
Q4 | $382K | Sell |
8,220
-1,492
| -15% | -$69.4K | 0.02% | 900 |
|
|
2022
Q3 | $504K | Sell |
9,712
-10,088
| -51% | -$524K | 0.02% | 899 |
|
|
2022
Q2 | $936K | Buy |
+19,800
| New | +$936K | 0.04% | 603 |
|
|
2021
Q3 | – | Sell |
-8,400
| Closed | -$370K | – | 1199 |
|
|
2021
Q2 | $370K | Buy |
+8,400
| New | +$370K | 0.04% | 585 |
|
|
2021
Q1 | – | Sell |
-6,694
| Closed | -$282K | – | 1025 |
|
|
2020
Q4 | $282K | Buy |
+6,694
| New | +$282K | 0.05% | 622 |
|